I confess that the terms you are using are not familiar to me. Could you provide more context as to what you mean by a "Drug Product Release facility?"
For example, are you talking about a facility that does testing to determine if a drug manufactured by a different company meets its release specifications? Are you talking about drugs that are under NDAs or ANDAs or OTC drugs being sold under drug monographs?
Thanks.
______________________________________________
Michael A. Swit
Special Counsel, FDA Law Practice
Duane Morris LLP
750 B Street, Suite 2900
San Diego, CA 92101-4681
P: +1 619 744 2215
F: +1 619 923 2648
C +1 760 815 4762
maswit@duanemorris.com Note: all postings by me on this forum represent my personal views and not necessarily those of my clients or my law firm. Further, my comments are not intended as legal advice but as the sharing of general knowledge and do not create an attorney-client relationship with any reader.
Please follow me on LinkedIN and Twitter:
http://www.linkedin.com/in/michaelswit https://twitter.com/FDACounsel -------------------------------------------
Original Message:
Sent: 10-19-2012 14:52
From: Andrea Gosda
Subject: Release Site
Does anyone know of any FDA legislation as to what is required to make a facility and Drug Product Release facility? Will an inspection be required?
-------------------------------------------
Andrea Gosda RAC
Associate Director CMC
Clark NJ
United States
-------------------------------------------